The prevention of diabetes and cardiovascular disease in people with schizophrenia - PubMed (original) (raw)
Review
doi: 10.1111/acps.12443. Epub 2015 May 15.
Affiliations
- PMID: 25976975
- DOI: 10.1111/acps.12443
Review
The prevention of diabetes and cardiovascular disease in people with schizophrenia
R I G Holt. Acta Psychiatr Scand. 2015 Aug.
Abstract
Objective: Primary prevention of diabetes and cardiovascular disease is an important priority for people with schizophrenia. This review aims to identify lifestyle and pharmacological interventions that reduce diabetes and cardiovascular disease in people with schizophrenia.
Method: PubMed and other electronic databases were searched to identify relevant articles.
Results: Lifestyle interventions that focus on diet and physical activity reduce the incidence of diabetes. Similar programmes in people with schizophrenia have led to significant weight loss and may reasonably be expected to reduce diabetes in the long-term. Metformin may be considered when lifestyle change is not feasible or effective. Lifestyle interventions, particularly smoking cessation, are likely to be effective in reducing cardiovascular disease in people with schizophrenia. Although cardiovascular prevention trials with statins have not been performed in people with schizophrenia, similar reductions in cholesterol has been seen as in the general population and statins should be considered for those at high risk. Traditional cardiovascular risk prediction models perform well in identifying those at high cardiovascular risk, but bespoke prediction models using data from people with schizophrenia perform better.
Conclusion: Reducing diabetes and cardiovascular disease requires a coordinated and concerted effort from mental and physical health teams working across primary and secondary care.
Keywords: cardiovascular disease; diabetes; prevention; schizophrenia; screening.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
- Effects of lifestyle changes to reduce risks of diabetes and associated cardiovascular risks: results from large scale efficacy trials.
Horton ES. Horton ES. Obesity (Silver Spring). 2009 Dec;17 Suppl 3:S43-8. doi: 10.1038/oby.2009.388. Obesity (Silver Spring). 2009. PMID: 19927146 Review. - A meta-review of lifestyle interventions for cardiovascular risk factors in the general medical population: lessons for individuals with serious mental illness.
Ward MC, White DT, Druss BG. Ward MC, et al. J Clin Psychiatry. 2015 Apr;76(4):e477-86. doi: 10.4088/JCP.13r08657. J Clin Psychiatry. 2015. PMID: 25919840 Review. - [Lifestyle intervention for the prevention of cardiovascular disease].
Fokkema MR, Muskiet FA, van Doormaal JJ. Fokkema MR, et al. Ned Tijdschr Geneeskd. 2005 Nov 19;149(47):2607-12. Ned Tijdschr Geneeskd. 2005. PMID: 16355572 Review. Dutch. - How can we promote smoking cessation in people with schizophrenia in practice? A clinical overview.
Stubbs B, Vancampfort D, Bobes J, De Hert M, Mitchell AJ. Stubbs B, et al. Acta Psychiatr Scand. 2015 Aug;132(2):122-30. doi: 10.1111/acps.12412. Epub 2015 Mar 6. Acta Psychiatr Scand. 2015. PMID: 25754402 Review. - The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan--Cardiovascular diseases.
Nishtar S, Faruqui AM, Mattu MA, Mohamud KB, Ahmed A. Nishtar S, et al. J Pak Med Assoc. 2004 Dec;54(12 Suppl 3):S14-25. J Pak Med Assoc. 2004. PMID: 15745323
Cited by
- Engagement in a virtual group-based walking intervention for persons with schizophrenia: a qualitative study.
Browne J, Battaglini C, Imamoglu A, Stiles B, Jarskog LF, Sheeran P, Abrantes AM, Elliott T, Gonzalez O, Penn DL. Browne J, et al. BMC Psychiatry. 2024 Nov 11;24(1):790. doi: 10.1186/s12888-024-06250-9. BMC Psychiatry. 2024. PMID: 39529016 Free PMC article. Clinical Trial. - Relationship between eating attitudes, depression, and insight in schizophrenic patients with and without type 2 diabetes mellitus: a comparative study in Guangdong, China.
Zhou W, Cao W, Wang W, Zeng G, Liang R, Liu C, Chen X, Lin W, Shi X, Zhou H, Gao Y, Chen W, Xiao L. Zhou W, et al. Front Psychiatry. 2024 Oct 3;15:1477953. doi: 10.3389/fpsyt.2024.1477953. eCollection 2024. Front Psychiatry. 2024. PMID: 39421064 Free PMC article. - Effects of Adapted Physical Activity on White Matter Integrity in Patients with Schizophrenia.
Leroux E, Masson L, Tréhout M, Dollfus S. Leroux E, et al. Brain Sci. 2024 Jul 15;14(7):710. doi: 10.3390/brainsci14070710. Brain Sci. 2024. PMID: 39061450 Free PMC article. - The lived experience of severe mental illness and long-term conditions: a qualitative exploration of service user, carer, and healthcare professional perspectives on self-managing co-existing mental and physical conditions.
Carswell C, Brown JVE, Lister J, Ajjan RA, Alderson SL, Balogun-Katung A, Bellass S, Double K, Gilbody S, Hewitt CE, Holt RIG, Jacobs R, Kellar I, Peckham E, Shiers D, Taylor J, Siddiqi N, Coventry P; DIAMONDS Research team. Carswell C, et al. BMC Psychiatry. 2022 Jul 19;22(1):479. doi: 10.1186/s12888-022-04117-5. BMC Psychiatry. 2022. PMID: 35850709 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical